ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Ginsenoside Rg3 enhances the radiosensitivity of lung cancer A549 and H1299 cells via the PI3K/AKT signaling pathway

Li, Jialin; Yang, Bo*南方医科大学; 1
In Vitro Cellular and Developmental Biology - Animal2023-2-15DOI: 10.1007/s11626-023-00749-3
13阅读
引用收藏
分享

摘要

Lung cancer is one of the most common cancers and the leading cause of cancer-related deaths in the world. Radiation is widely used for the treatment of lung cancer. However, radioresistance and toxicity limit its effectiveness. Ginsenoside Rg3 (Rg3) is a positive monomer extracted from ginseng and has been shown to the anti-cancer ability on many tumors. The aim of the present study was to ascertain whether Rg3 is able to enhance the radiosensitivity of lung cancer cells and investigate the underlying mechanisms. The effect of Rg3 on cell proliferation was examined by Cell Counting Kit-8 (CCK-8) and radiosensitivity was measured by colony formation assay. Flow cytometry, transwell, and wound healing assay were used to determine apoptosis, cell cycle, and metastasis. Western blot was used to detect the main protein levels of the PI3K/AKT signaling pathway. We found that Rg3 inhibited cell proliferation, promoted apoptosis, and suppressed migration and invasion in radio-induced lung cancer cells. In addition, Rg3 increased the proportion of G2/M phase cells and inhibited the formation of cell colonies. Moreover, Rg3 decreased the expression levels of PI3K, p-AKT, and PDK1 in radio-induced cells. These findings indicate that Rg3 may be able to enhance the radiosensitivity in lung cancer cells by the PI3K/AKT signaling pathway. These results demonstrate the therapeutic potential of Rg3 as a radiosensitizer for lung cancer.

学科与关键词

关键词
Ginsenoside Rg3RadiosensitivityLung cancerPI3KAKT signaling pathway
相关
加载中…
  • Ginsenoside Rk1 attenuates radiation-induced intestinal injury through the PI3K/AKT/mTOR pathway
    Wang, Yilin; Su, Peizhu; Zhuo, Zewei; Jin, Yabin; Zeng, Ruijie; Wu, Huihuan; Huang, Huiwen; Chen, Hao*; Li, Zhaotao*; Sha, Weihong*Biochemical and Biophysical Research Communications, 2023, 643: 111-120.
  • Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors
    Kasun, Wanigasooriya; Robert, Tyler; Joao D., Barros-Silva; Yashashwi, Sinha; Tariq, Ismail; Andrew D., BeggsCancers, 2020, 12(5): 1278.被引 7
  • GATA3 Exerts Distinct Transcriptional Functions to Regulate Radiation Resistance in A549 and H1299 Cells
    Wang, Rui; Yi, Junxuan; Gao, Hui; Wei, Xinfeng; Shao, Lihong; Wang, Mingwei; Xu, Weiqiang; Yin, Xiaoshu; Shen, Yannan; Wang, Zhicheng; Wei, Wei*; Jin, Shunzi*Oxidative Medicine and Cellular Longevity, 2022, 2022: 9174111.
查看全部 →

发表信息

论文状态
公开发表
期刊
In Vitro Cellular and Developmental Biology - Animal
发表日期
2023-02-15
DOI
10.1007/s11626-023-00749-3
语言
ENGLISH
成果收录
SCIE
资助标注
Wuhan Young and Middle-aged Medical Backbone Personnel Training Project and Scientific Research Project of Hubei Provincial Health Commission [WJ2021M221]

作者

  • L

    Li, Jialin (第一作者)

    1 · southern med univ

  • Y

    Yang, Bo (通讯)

    1 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417